Alamar Biosciences, Inc.
NASDAQ:ALMRBiotechnology
+$1.11 today
- Market cap
- $2.12B
- Beta
- 0.00
- P/E (TTM)
- -47.5
- EPS (TTM)
- -$0.45
Volume 0.53M
Average 0.38M
ALMR Total Non-current Assets
All assets not expected to be converted to cash within one year.
Alamar Biosciences, Inc.NASDAQ: ALMR
Total Non-current Assets · Q2 FY2026 · quarter ended Jun 2026
Total non-current assets of $59.59M in Q2 FY2026
Q2 FY2026 total non-current assets was $59.59M.
Context
- Total non-current assets amounted to 15.2% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 45.29M USD
- Year-over-year change
- +5.8%
- 1-year CAGR
- +5.8%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.29M | +5.8% |
| FY2024 | 2024-12-31 | 42.81M | — |
Total Non-current Assets vs competitors
How ALMR compares with its peers on the latest reported figures
- ALMR's Jun 2026 total non-current assets of $59.59M is the lowest of the 9 companies compared; the peer median is $231.08M.
- Total non-current assets amounts to 15.2% of total assets for ALMR, versus a peer median of 35.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.81B | -5.5% | -1.4% | 68.7% | |
| Mar 2026 | $412.85M | -0.7% | -23.5% | 52.8% | |
| Sep 2026 | $384.58M | +24.5% | +3.0% | 34.3% | |
| Sep 2026 | $344.5M | -6.3% | -3.2% | 32.4% | |
| Mar 2026 | $117.66M | -50.1% | -14.5% | 18.4% | |
| Mar 2026 | $90.54M | -1.6% | +21.3% | 33.3% | |
| Mar 2026 | $78.95M | -8.3% | -19.4% | 44.4% | |
| Mar 2026 | $78.38M | +166.5% | +27.9% | 36.7% | |
ALMRAlamar Biosciences, Inc. | Jun 2026 | $59.59M | — | — | 15.2% |
| Peer median (excluding ALMR) | $231.08M | -3.5% | -2.3% | 35.5% | |
Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Cash & Equivalents | 26.77M | 30M |
| Short-term Investments | 52.59M | 0 |
| Net Receivables | 7.32M | 12.75M |
| Inventory | 14.41M | 38.48M |
| Other Current Assets | 5.61M | 13.47M |
| Total Current Assets | 106.7M | 94.71M |
| Property, Plant & Equipment (Net) | 35.1M | 36.63M |
| Goodwill | 0 | 0 |
| Intangible Assets | 2.04M | 1.99M |
| Long-term Investments | 0 | 0 |
| Tax Assets | 0 | 0 |
| Other Non-current Assets | 5.67M | 6.67M |
| Total Non-current Assets | 42.81M | 45.29M |
| Total Assets | 149.51M | 139.99M |
| Account Payables | 6.19M | 5.87M |
| Short-term Debt | 0 | 0 |
| Tax Payables | 0 | 0 |
| Deferred Revenue | 575K | 470K |
| Other Current Liabilities | 5.42M | 7.59M |
| Total Current Liabilities | 16.59M | 23.73M |
| Long-term Debt | 0 | 9.81M |
| Deferred Tax Liabilities | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 |
| Other Non-current Liabilities | 235.14M | 235.84M |
| Total Non-current Liabilities | 266.33M | 275.22M |
| Total Liabilities | 282.92M | 298.95M |
| Common Stock | 1K | 1K |
| Retained Earnings | (138.96M) | (168.78M) |
| Accumulated OCI | 149K | (72K) |
| Other Stockholders Equity | 0 | 0 |
| Minority Interest | 0 | 0 |
| Total Equity | (133.41M) | (158.95M) |
| Total Debt | 33.1M | 41.47M |
| Net Debt | 6.33M | 11.47M |
Alamar Biosciences, Inc.
NASDAQ:ALMR
Intrinsic Alpha fair value
Locked
Current Price
$30.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.